Literature DB >> 15187680

Juxtafoveal telangiectasis-a name change?

Frederick H Davidorf1, Melissa D Pressman, Robert B Chambers.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15187680     DOI: 10.1097/00006982-200406000-00028

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  6 in total

1.  Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.

Authors:  Buğra Karasu; Betul Onal Gunay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-25       Impact factor: 3.117

Review 2.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

3.  [Therapeutic approaches for macular telangiectasia type 2: status quo and perspectives].

Authors:  F G Holz; T F C Heeren; E Krüger; M Zeimer; D Pauleikhoff; P Charbel Issa
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

4.  Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.

Authors:  Lydia Sauer; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Ophthalmol Retina       Date:  2017-12-08

5.  Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis.

Authors:  Vladimir Surguch; Maria-Andreea Gamulescu; Veit-Peter Gabel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-22       Impact factor: 3.535

6.  Optical Coherence Tomography Angiography Findings in Type-2 Macular Telangiectasia.

Authors:  Hilal Nalcı; Figen Şermet; Sibel Demirel; Emin Özmert
Journal:  Turk J Ophthalmol       Date:  2017-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.